Phibro Animal Health Corp...

NASDAQ: PAHC · Real-Time Price · USD
30.43
-0.14 (-0.46%)
At close: Aug 15, 2025, 9:55 AM

Phibro Animal Health Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
347.82M 309.26M 260.43M 273.16M 263.22M 249.94M 231.3M 255.05M 245.67M 244.65M 232.52M 255.3M 239.62M 232.71M 214.66M 220.3M 211.73M 206.15M 195.19M
Cost of Revenue
243.26M 207.39M 176.94M 186.39M 184.35M 171.33M 163.6M 178.38M 170.13M 167.26M 163.88M 176.8M 167.99M 162.04M 149.99M 150.5M 142.56M 137.88M 131.07M
Gross Profit
104.57M 101.87M 83.5M 86.78M 78.87M 78.62M 67.7M 76.67M 75.54M 77.39M 68.65M 78.5M 71.63M 70.67M 64.68M 69.8M 69.17M 68.27M 64.12M
Operating Income
33.52M 25.53M 17.7M 12.64M 20.19M 15.7M -700K 23.77M 18.55M 15.84M 13.68M 14.49M 19.19M 22.29M 14.61M 19.2M 20.13M 19.89M 15.69M
Interest Income
298K 168K 531K 1.26M 1.07M 1.06M 1.08M 948K 1.03M 744K 628K 304K 187K 149K 176K 129K 148K 262K 299K
Pretax Income
29.69M 4.84M 9.62M 6.41M 12.92M 3.56M -12M 21.44M 15.1M 12.11M 5.42M 12.4M 26.83M 23.53M 9.6M 16.1M 17.78M 16.05M 16.51M
Net Income
20.88M 3.19M 6.97M 752K 8.4M 1.27M -8M 11.5M 10.04M 7.21M 3.86M 7.5M 17.69M 17.46M 6.53M 17.1M 12.16M 12.8M 12.3M
Selling & General & Admin
71.05M 76.34M 65.8M 74.14M 58.68M 62.91M 68.5M 52.9M 56.99M 61.54M 54.96M 55.5M 52.43M 48.38M 50.07M 50.7M 49.03M 48.38M 48.43M
Research & Development
n/a n/a n/a 29.19M n/a n/a n/a 24.39M n/a n/a n/a 20.83M n/a n/a n/a 17.76M n/a n/a n/a
Other Expenses
n/a n/a n/a 12.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
71.05M 76.34M 65.8M 74.14M 58.68M 62.91M 68.5M 52.9M 56.99M 61.54M 54.96M 55.5M 52.43M 48.38M 50.07M 50.7M 49.03M 48.38M 48.43M
Interest Expense
13.1M 9.16M 8.17M 9.64M 9.29M 9.37M 9.21M 8.81M 7.9M 6.93M 4.91M 3.06M 2.3M 3.98M 3.93M 3.2M 3.08M 2.65M 2.3M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
314.31M 283.73M 242.73M 260.53M 243.03M 234.24M 232.1M 231.28M 227.12M 228.8M 218.84M 232.3M 220.43M 210.42M 200.05M 201.2M 191.6M 186.26M 179.51M
Income Tax Expense
8.81M 1.65M 2.65M 5.66M 4.52M 2.29M -4M 9.94M 5.06M 4.9M 1.56M 4.9M 9.14M 6.07M 3.06M -1M 5.62M 3.25M 4.21M
Shares Outstanding (Basic)
40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.48M 40.45M 40.45M
Shares Outstanding (Diluted)
40.71M 40.72M 40.58M 40.6M 40.52M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M 40.5M
EPS (Basic)
0.52 0.08 0.17 0.02 0.21 0.03 -0.2 0.28 0.25 0.18 0.10 0.19 0.44 0.43 0.16 0.42 0.30 0.32 0.30
EPS (Diluted)
0.51 0.08 0.17 0.02 0.21 0.03 -0.2 0.28 0.25 0.18 0.10 0.19 0.44 0.43 0.16 0.42 0.30 0.32 0.30
EBITDA
51.38M 25.53M 26.8M 25.25M 29.84M 24.92M -726K 38.83M 28.31M 24.34M 22.13M 23.84M 28M 30.3M 22.47M 27.17M 28.05M 27.98M 23.72M
EBIT
38.77M 14M 17.79M 12.14M 18.31M 8.97M -6.66M 23.77M 19.82M 16.55M 8.96M 15.63M 29.8M 26.48M 12.51M 19.16M 20.64M 19.31M 19.4M
Depreciation & Amortization
12.62M 11.57M 9M 9.2M 9.2M 8.91M 8.87M 8.57M 8.49M 8.5M 8.45M 8.4M 8.45M 8M 7.85M 7.84M 7.92M 8.09M 8.04M